Mitotane Therapy in Adrenocortical Cancer Induces CYP3A4 and Inhibits 5α-Reductase, Explaining the Need for Personalized Glucocorticoid and Androgen Replacement (Q56964274)
Jump to navigation
Jump to search
scientific article published on 16 November 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Mitotane Therapy in Adrenocortical Cancer Induces CYP3A4 and Inhibits 5α-Reductase, Explaining the Need for Personalized Glucocorticoid and Androgen Replacement |
scientific article published on 16 November 2012 |
Statements
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement (English)
Paul M Stewart
Martin Fassnacht
Bruno Allolio
Franco Mantero
Beverly A Hughes
Donna M O'Neil
Cedric H L Shackleton
Mark Sherlock
Petra Schneider
Xavier Bertagna
Peter Nightingale
16 November 2012